244 related articles for article (PubMed ID: 36248882)
1. Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.
Bhuiyan TR; Al Banna H; Kaisar MH; Karmakar PC; Hakim A; Akter A; Ahmed T; Tauheed I; Islam S; Hasnat MA; Sumon MA; Rashed A; Ghosh S; Clemens JD; Banu S; Shirin T; Weiskopf D; Sette A; Chowdhury F; Qadri F
Front Immunol; 2022; 13():929849. PubMed ID: 36248882
[TBL] [Abstract][Full Text] [Related]
2. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4
Coulon PG; Prakash S; Dhanushkodi NR; Srivastava R; Zayou L; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Nesburn AB; Kuppermann BD; Bahraoui E; Vahed H; Gil D; Jones TM; Ulmer JB; BenMohamed L
Front Immunol; 2024; 15():1343716. PubMed ID: 38605956
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
[TBL] [Abstract][Full Text] [Related]
4. Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh.
Akhtar M; Basher SR; Nizam NN; Kamruzzaman M; Khaton F; Banna HA; Kaisar MH; Karmakar PC; Hakim A; Akter A; Ahmed T; Tauheed I; Islam S; Ahmmed F; Mahamud S; Hasnat MA; Sumon MA; Rashed A; Ghosh S; Calderwood SB; Harris JB; Charles RC; LaRocque RC; Ryan ET; Banu S; Shirin T; Chowdhury F; Bhuiyan TR; Qadri F
Front Immunol; 2022; 13():1052374. PubMed ID: 36578502
[TBL] [Abstract][Full Text] [Related]
5. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
Front Immunol; 2021; 12():684014. PubMed ID: 34194438
[TBL] [Abstract][Full Text] [Related]
6. Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Ssali I; Mugaba S; Watelo AK; Bemanzi J; Katende JS; Oluka GK; Ankunda V; Baine C; Kato L; ; Onyachi N; Muwanga M; Jjuuko M; Kayiwa J; Nsereko C; Auma BO; Weiskopf D; Sette A; Lutalo T; Musenero M; Kaleebu P; Serwanga J
Int J Infect Dis; 2023 Nov; 136():49-56. PubMed ID: 37683720
[TBL] [Abstract][Full Text] [Related]
7. Helminth antigens differentially modulate the activation of CD4
Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
[TBL] [Abstract][Full Text] [Related]
8. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
Front Immunol; 2022; 13():817905. PubMed ID: 35185909
[TBL] [Abstract][Full Text] [Related]
9. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection.
Moga E; Lynton-Pons E; Domingo P
Front Immunol; 2022; 13():904686. PubMed ID: 35833134
[TBL] [Abstract][Full Text] [Related]
10. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.
Akter A; Ahmed T; Tauheed I; Akhtar M; Rahman SIA; Khaton F; Ahmmed F; Ferdous J; Afrad MH; Kawser Z; Hossain M; Khondaker R; Hasnat MA; Sumon MA; Rashed A; Ghosh S; Calderwood SB; Charles RC; Ryan ET; Khatri P; Maecker HT; Obermoser G; Pulendran B; Clemens JD; Banu S; Shirin T; LaRocque RC; Harris JB; Bhuiyan TR; Chowdhury F; Qadri F
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010102. PubMed ID: 34982773
[TBL] [Abstract][Full Text] [Related]
11. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
12. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
13. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
[TBL] [Abstract][Full Text] [Related]
14. High Frequencies of Functional Virus-Specific CD4
Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
Front Immunol; 2021; 12():748881. PubMed ID: 34858405
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
[TBL] [Abstract][Full Text] [Related]
16. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
17. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
Front Immunol; 2021; 12():797919. PubMed ID: 34975908
[TBL] [Abstract][Full Text] [Related]
18. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
Front Immunol; 2021; 12():636768. PubMed ID: 33777028
[TBL] [Abstract][Full Text] [Related]
19. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.
Gao L; Zhou J; Yang S; Wang L; Chen X; Yang Y; Li R; Pan Z; Zhao J; Li Z; Huang Q; Tang J; Hu L; Liu P; Zhang G; Chen Y; Ye L
Signal Transduct Target Ther; 2021 Mar; 6(1):113. PubMed ID: 33686064
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses.
Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA;
Cell Rep; 2022 Feb; 38(6):110345. PubMed ID: 35090598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
